Page last updated: 2024-11-07

paramethasone and Acute Myelogenous Leukemia

paramethasone has been researched along with Acute Myelogenous Leukemia in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Minoshima, S1

Other Studies

1 other study available for paramethasone and Acute Myelogenous Leukemia

ArticleYear
[Treatment of acute childhood leukemia].
    Gan no rinsho. Japan journal of cancer clinics, 1968, Volume: 14, Issue:9

    Topics: Age Factors; Antineoplastic Agents; Cyclophosphamide; Female; Humans; Leukemia; Leukemia, Lymphoid;

1968